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ABSTRACT OF THE DISSERTATION
Towards the Discovery of Prognostic Biomarkers for Glioblastoma
Using Resting-State Functional Connectivity
by
Andy G. S. Daniel
Doctor of Philosophy in Biomedical Engineering
Washington University in St. Louis, 2021
Professor Eric Leuthardt, Chair
Gliomas are highly diffusive, primary brain tumors. The most malignant form,
glioblastoma, has a dismal survival rate: 14-17 months following the current standard of care,
which consists of surgery, radiation, and chemotherapy. Insights into the molecular, cellular, and
microenvironmental components of glioblastoma have revealed a vast array of factors utilized to
support its proliferation, infiltration, and resistance to treatment. Recent advancements have also
identified diagnostic and prognostic biomarkers that are now being used to guide treatment
planning. However, survival has improved only marginally, thus emphasizing the continued need
for novel biomarkers and treatment strategies.
Given its delicate location in the brain, extreme care is taken to limit damage while
maximizing surgical resections. As such, brain mapping is routinely performed to identify areas
responsible for functions that if impaired, would lead to life-altering deficits. Resting-state
functional magnetic resonance imaging (rs-fMRI) is one technique recently employed for
preoperative mapping of brain function noninvasively. Using blood-level-dependent-oxygen
(BOLD) signals, rs-fMRI identifies brain regions that are temporally synchronous (i.e.,
functionally connected,) and are consistent with known brain networks. In research settings, rsx

fMRI is used to understand brain function and how it is altered by disease. Here, we considered
rs-fMRI as a potential tool to identify glioma characteristics and glioma-induced changes in
brain function that may have prognostic value for preoperative planning.
As gliomas are heterogenous and infiltrative, preserved function can be found within
tumor boundaries. This observation, however, has been limited to the somatomotor and language
systems due to routine intraoperative stimulation mapping of these cortical regions, which
ignores crucial functionality elsewhere. Moreover, function within tumor boundaries may vary
across patients and its prognostic significance remains ambiguous. Using rs-fMRI, we examined
the extent to which functional connectivity is preserved in glioblastoma. Our results demonstrate
that functional connectivity can be identified within most glioblastoma tumors and its strength
may serve as a survival biomarker before treatment interventions. Thus, intratumor functional
connectivity provides an innovative method to assess tumor malignancy.
Tumor malignancy has been shown to modify the extent of connectivity disturbances
across the ipsilesional and contralesional hemispheres. Since high functional connectivity
between homologous brain regions (i.e., homotopic connectivity) is a common feature of normal
brain functioning, the neuronal pathways facilitating these connections may be disturbed in
glioma patients. Further, the degree of this disruption may depend on tumor aggressiveness.
Thus, taken together, the variability of this homotopic connectivity may have prognostic
implications. Using rs-fMRI, we assessed homotopic connectivity differences in low- and highgrade glioma patients and found consistent associations between tumor severity and altered
connections. Furthermore, homotopic connectivity was positively correlated with overall
survival, with higher connectivity in the somatomotor network demonstrating statistically
significant improvements in median overall survival. Therefore, understanding homotopic

xi

connectivity changes in glioma patients provides novel insight into brain dysfunction and may
impact treatment strategies.
In summary, we showed that rs-fMRI can provide deeper insights into tumor-induced
changes in brain function beyond what is traditionally assessed for preoperative planning. Future
studies should investigate whether the identified findings are consistent in larger populations and
across various demographics. Overall, our findings suggest a potential role for rs-fMRI as a
driver of biomarker discovery for glioma outcomes.
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Chapter 1: Introduction
1.1 Clinical Significance
Gliomas are a diverse group of diffusely infiltrative primary brain tumors 1. Unfortunately, the
majority of sufferers are plagued with high rates of morbidity and mortality 2. Gliomas account
for approximately 30% of all primary brain tumors, and 80% of all malignant brain tumors are
gliomas 3. In the United States, ~20,000 cases of glioma are diagnosed each year, with the
number of cases expanding to ~100,000 globally 4,5. Common glioma types include pilocytic
astrocytoma (primarily diagnosed in children and young adults), diffuse astrocytoma,
oligodendroglioma, anaplastic astrocytoma, anaplastic oligodendroglioma, ependymoma, and
glioblastoma. Glioblastoma is the most common form, accounting for 70-75% of glioma
diagnoses 3,6.
The prevalence of glioblastoma is only eclipsed by its malignancy; it is the most lethal
form of glioma. Patients with glioblastoma have a median survival of 14-17 months with a 2year survival rate of ~14.8% and a 5-year survival rate of <5% 3,4,6. Other forms of glioma have
more favorable prognoses, although it is possible for lower grade gliomas to mutate into the
more aggressive form 3. The standard of care for glioma has not changed appreciably in the past
two decades with surgery, radiotherapy, and chemotherapy being the mainstays of treatment 7,8.
Despite current treatments however, malignant gliomas tend to recur, having a typical median
progression free survival (PFS) time of less than one year 9,10. Additionally, given the delicate
location of these tumors, many patients suffer with substantial neurological deficits pre- and
post-treatment 11–14. Moreover, costs associated with initial and repeated treatments are not
trivial, making glioma care an increasingly expensive endeavor for patients and their caregivers
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15–18

.

1.2 Intrinsic Factors Promoting Glioma Malignancy: Tumor
Heterogeneity
Malignant gliomas are characterized by an extraordinary degree of molecular and cellular
heterogeneity not only across patients but also distributed within tumor subpopulations 19. This
variability has far reaching implications for care as unrepresentative or insufficient tissue
sampling obtained for histopathological assessment may lead to misdiagnoses or be inadequate
for patient-tailored interventions 20,21.

1.2.1 Molecular heterogeneity
Subpopulations of malignant glioma consist of genomic differences, with certain alterations
shown to relate to tumor lineage, disease grading, response to various treatments, and confer
prognostic value 1,3,6,22. Of the several alterations investigated, O-6-methylguanine-DNA
methyltransferase (MGMT) promoter methylation, isocitrate dehydrogenase (IDH) mutation
status, and 1p/19q co-deletion status are among those extensively studied as they have
demonstrated efficacy as prognostic biomarkers 3,6,23.
Promoter methylation of the MGMT gene, which encodes a DNA-repair protein, results
in epigenetic silencing and reduces DNA-repair activity 24. This reduction results in increased
sensitivity to chemotherapy agents, such as temozolomide. In a foundational study, patients with
MGMT promoter-methylated gliomas were shown to receive a survival benefit when treated
with temozolomide compared to patients without MGMT promoter methylation 24. Several
clinical trials have confirmed these results, therefore highlighting the importance of molecular
profiling in treatment planning 6.
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The World Health Organization (WHO) updated the classification of adult gliomas to
include IDH mutation status and 1p/19q co-deletion status, as they have shown reliable
associations with tumor malignancy and survival 6,25. Gliomas that are IDH-mutant and 1p/19q
co-deleted are classified as oligodendrogliomas and have the most favorable outcomes (median
survival approximately 17.5 years) 3,6,26. On the other hand, IDH-mutant gliomas with 1p/19q
status intact are astrocytoma variants with intermediate outcomes, while IDH-wildtype gliomas
(WHO III astrocytoma, WHO IV glioblastoma) have the poorest prognoses 3,6,23. IDH mutations
are less common in glioblastoma (5-10%), underscoring the need to identify more prognostic
biomarkers for stratifying IDH-wildtype patients 3,27–29.

1.2.2 Cellular heterogeneity
Cellular diversity in malignant gliomas considerably contributes to patient morbidity.
Transcriptional profiling of glioblastoma identified four subtypes that have differing responses to
therapy: proneural, neural, classical, and mesenchymal 30,31. These subtypes can co-exist within
the same tumor, albeit at different concentration levels 19. Moreover, a subset of cells may exist
in a stem cell-like state and promote proliferation, resistance to conventional treatments, and
recurrence 19,32–34. Additionally, these cells have been shown to differentiate into cells of neural
and nonneural lineages that can facilitate a favorable environment for further tumor growth and
infiltration 19,35,36. Furthermore, due to the rapid proliferation of glioma cells, lack of adequate
blood supply and oxygen can induce genetic changes promoting a more migratory phenotype 36–
38

. This enables the cancer cells to invade the brain parenchyma beyond the tumor nidus. Thus,

the cellular heterogeneity of gliomas is an essential contributor to their malignancy and pose a
major challenge for developing treatments. However, understanding this innate complexity and
the bidirectional interactions with the local and distal environment provide opportunities to be
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more comprehensive and rigorous in identifying novel biomarkers and therapeutics.

1.3 Extrinsic Factors Promoting Glioma Malignancy: Tumor
Microenviroment
Growing gliomas disrupt the homeostatic structure of the brain. In particular, the vasculature can
be grossly affected because its maintenance requires the synergistic cooperation of three different
cell types: endothelial cells, pericytes, and astrocytes 39,40. Displacement of pericytes and
astrocytes by tumor cells diminishes the integrity of the tight junctions formed with the
endothelium and consequently alters the local blood-brain barrier they create 39–41. Under normal
conditions, the blood-brain barrier selectively limits the movement of molecules between the
vasculature and the brain parenchyma 42. Additionally, an intact blood-brain barrier is a
prerequisite for neurovascular coupling, the mechanism by which neuronal and astrocytic
signaling regulate local cerebral blood flow to deliver an adequate supply of oxygen and
metabolites to active neurons 43,44. In the presence of glioma cells, neurovascular uncoupling can
lead to oxygen-deprived environments, which not only engender cell death, but select for
migratory phenotypes in glioma cells, therefore facilitating further invasion 37,38,45. Conversely,
the breakdown of the blood-brain barrier by malignant gliomas is used clinically with the
introduction of gadolinium-contrast to the bloodstream to image areas of tumor infiltration 46.
Like tumors originating at other locations in the body, malignant gliomas can elicit
angiogenesis 39,47. This process generates new blood vessels by recruiting the pre-existing local
vasculature. These glioma vessels are morphologically distinct from the normal microvasculature
with a disorganized structure, larger diameters, and greater permeability 39. These vessels are
inefficient and provide the tumor with low levels of oxygen and nutrients leading to areas of
4

substantial hypoxia and necrosis 37,39,48. Tumor necrosis is a diagnostic feature of glioblastoma,
thus demonstrating the intrinsic inadequacy of tumor vasculature in meeting the metabolic
demands of the rapidly proliferating cells 39,49. As vascular endothelial growth factor (VEGF) is a
primary driver of tumor vessel formation, several studies and clinical trials have sought to
develop anti-VEGF therapies to improve outcomes 39. Although this is still an active area of
investigation, to date, limited efficacy has been shown clinically 39.
In addition to stimulating blood vessel growth for tumor proliferation, gliomas co-opt
several aspects of the brain parenchyma to enhance progression and invasion: preferential
anatomical pathways, secreted factors in the microenvironment, and native brain cells 50. This
co-option is similar to mechanisms utilized by the central nervous system during developmental
migration 51. For example, using microenvironmental cues, glioma cells preferentially travel
along white matter tracts 52,53. This conduit has been repeatedly demonstrated to facilitate spread
to regions far beyond the tumor mass, including the contralesional hemisphere 54–56. Moreover,
gliomas benefit from paracrine signaling as parenchymal cells, such as neurons and astrocytes,
secrete chemokines and growth factors that support tumor motility 50. Microglia, macrophage
cells in the nervous system, contradictorily promote both tumor suppression and glioma invasion
50,57

. Neurotransmitters, such as glutamate, also enhance proliferation though both autocrine and

paracrine mechanisms 51. Recent studies by the Monje group demonstrated that neural activity is
a striking driver of glioblastoma growth in a similar manner to its effect on neural and glial
progenitor cells 58,59. Bidirectional electrochemical communication between neurons and glioma
cells forms a coupled network that stimulates progression 59. Therefore, the complex interplay
between glioma cells and the microenvironment demonstrates a dynamic milieu that reinforces
tumor pervasiveness at the expense of normal brain functioning.

5

The recent discovery of glioma communication through cellular protrusions surprisingly
revealed yet another insidious mechanism through which gliomas maintain their aggressiveness
and remain currently incurable 60. These protrusions known as tumor microtubes (TMs) enable
glioma cells to interconnect and form a network syncytium which communicates via intercellular
calcium waves across gap junctions 60. Interestingly, TMs are preferentially expressed in
glioblastoma, with TM length strongly associated with WHO grade 60. Conversely, they are not
expressed in 1p/19q co-deleted gliomas i.e., oligodendrogliomas, which have substantially longer
median survival compared to glioblastoma 60. In fact, TMs have been shown to directly confer
resistance to interconnected glioma cells from chemotherapy and radiotherapy 60,61. Additionally,
TMs are implicated in tumor recurrence as they facilitate the dissemination of connected tumor
nuclei at resection sites following surgery 61. Thus, TMs are yet another tool used by malignant
gliomas to survive. However, their discovery may usher in novel therapeutics that specifically
target this network structure 28. With several potential therapeutic avenues in the pipeline to treat
gliomas and extend survival, it is important in clinical practice to also factor in other patient
outcome measures, such as preservation of cognitive function and quality of life 62,63. For this
reason, cortical mapping plays an essential role in maximizing patient outcomes 64.

1.4 Cortical Mapping for Glioma Resection
Tumor location in the brain is a critical factor in treatment planning 65,66. Although surgical
resection remains the standard of care, its benefits must be carefully balanced with the risk of
life-altering neurological deficits 67. The extent of surgical resection of malignant gliomas is
strongly correlated with overall survival (OS) and progression-free survival (PFS). As a result,
the goal of surgery is to maximize tumor resection while limiting injury to areas associated with
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eloquent cortex i.e., brain regions that are responsible for overt functions, such as movement,
sensation, and language 64,68. Tumors near eloquent cortex are generally mapped using
complementary techniques to augment the information acquired by each 64,69. However, these
methods are imperfect, and their limitations should be considered when deciding upon use.
Common techniques relevant to this thesis are described below.

1.4.1 Direct electrical stimulation
Direct electrical stimulation (DES) is generally considered the gold standard for brain mapping
69–71

. When placed on the cortical surface, monopolar or bipolar electrodes are used to excite the

underlying neurons by altering their membrane potentials and generating action potentials 70.
Intraoperatively, this stimulation can elicit involuntary motor responses and dysesthesia as well
as probe various aspects of visuo-spatial processing, memory, and language function, being
dependent on the site of application 70. The sensitivity of stimulation mapping to delineate
functional boundaries of eloquent cortex enables neurosurgeons to test whether bordering tumors
can be safely resected, therefore reducing the likelihood of postoperative deficits 72. Moreover,
functional tissue can exist within tumor boundaries making an accurate assessment of intratumor
function imperative in the decision-making process 73–75. However, there are certain limitations
that impact its usage and interpretation.
First, it should be emphasized that DES mapping is a highly invasive procedure.
Following a craniotomy, electrodes are placed onto the cortical surface and stimulated.
Therefore, it has the risks associated with awake craniotomies including anesthesia
complications, infections, bleeding, brain swelling, and death 76–78.
Secondly, except for evoking motor responses, other functions tested require the patient
to be awake and alert during surgery70. Since patients must follow instructions, this immediately
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precludes those who are severely impaired and young children 79,80. Additionally, cortical
mapping can be an extensive process, with intraoperative patient fatigue a common occurrence
81

. This may affect a patient’s ability to comply, jeopardizing the accuracy of function

localization 70.
Thirdly, DES may evoke seizure activity 82,83. This may be suitable in epilepsy surgery to
probe seizure foci 69. However, in glioma surgery, seizures have the undesirable effect of
creating false-positives and potentially damaging the cortex 70,84. Additionally, evoked seizures
can also lead to aborted procedures 71,83. Optimizing stimulation current levels minimizes this
risk; however, the incidence is widely variable across institutions at 2.5% – 54% 70,85.
Finally, stimulation mapping is inherently non-specific 69,70. Due to the electrically
coupled nature of the brain, stimulation current elicited at one location can initialize action
potentials that propagate to distal axons 69,70. These distal sites may then be activated and evoke a
functional response despite no activation from the stimulation site itself 86. In this case, the
stimulation site would be considered eloquent and essential for preservation. Studies have
demonstrated that resection of these falsely eloquent regions may not result in postoperative
deficits 86,87. Therefore, the potential for remote spread needs to also be factored in when
isolating functional boundaries.
Taking these limitations into account, complementary methods have been added to the
neurosurgeon’s arsenal to help identify eloquent cortex noninvasively, thus improving presurgical planning of glioma treatment 88–90.

1.4.2 Task-based functional magnetic resonance imaging (fMRI) for presurgical planning
In the 1980s, it was discovered that neuronal activity evokes a change in local cerebral blood
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flow that is greater than oxygen consumption 91. This mismatch between brain activity, oxygen
demand, and tissue oxygenation alters local magnetic resonance properties and forms the basis of
blood-oxygen-level-dependent (BOLD) contrast, a crucial component of functional magnetic
resonance imaging (fMRI) 92. Subsequent studies soon showed that in humans, sensorimotor and
cognitive tasks elicit local changes in BOLD contrast thereby allowing function to be localized
noninvasively, ushering in task-based fMRI 93. This technique allowed for noninvasive eloquent
mapping of the entire brain, removing the risks of surgery and no longer limited mapping to only
areas accessible by surface or depth electrodes 79,94.
When applied to a clinical population however, task-based fMRI is not always ideal in a
pre-surgical setting. Like DES, task-based fMRI necessitates a patient’s ability to follow tasks
80,95

. Therefore, cognitively impaired patients and young children are again excluded 80.

Additionally, like DES, many tasks are needed to detect multiple brain networks, potentially
prolonging mapping and increasing patient fatigue 70,89,96. These constraints can be overcome
using resting-state fMRI, the main technique employed in this thesis.

1.4.3 Resting-State fMRI (rs-fMRI) for pre-surgical planning
When an individual is at rest in an MRI scanner, studies have repeatedly demonstrated that the
low frequency BOLD signal fluctuations of the brain are synchronous across disparate areas 97–
99

. Temporally coherent brain regions are said to be functionally connected and belong to the

same resting-state networks (RSNs). Of current clinical relevance is the high correspondence of
these networks to task-specific functional areas identified through DES and task-based fMRI i.e.,
eloquent cortex 79,100,101. As such, frequently mapped networks include the language network,
auditory network, somatosensory network, and visual network, although networks responsible
for higher cognitive functions can also be mapped 88,94,102.
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Unlike past lesion studies which necessarily confined brain function inferences to
sequalae, resting-state fMRI (rs-fMRI) studies have demonstrated that the brain is a highly
networked structure 98,103–105. Corresponding to brain function assessments with DES, injury to
one component of a RSN may lead to significant deficits if the damaged area was functionally
essential 106–108. However, compensation or remapping via adjacent or distal locations can occur
109,110

. Furthermore, the recent application of network science and graph theory to RSN mapping

has generated an additional toolset to identify the criticality of regions for specific functions 111.
Such insight may allow neurosurgeons to preoperatively determine whether a region could be
theoretically sacrificed to maximize the extent of tumor resection 111–113. Given these findings,
the traditional method of localized mapping near tumor sites may not be wholly representative of
the information that is needed to make truly informed decisions about patient care in the setting
of brain tumors.
An aspect that is currently overlooked in pre-surgical planning of glioma surgeries is the
importance of higher order functions on patient outcomes 114,115. Certain cortical regions are
responsible for executive functions such as planning, top-down control, and decision making 116–
121

. Traditionally, however, these areas are not considered essential for preservation and are not

consistently mapped despite growing evidence of a link between executive functioning and poor
survival in patients 114,122. The use of whole brain mapping techniques such as rs-fMRI enables
clinicians to identify the regions responsible for these functions and would provide
neurosurgeons with additional information to guide their surgical approach 80,112. Furthermore,
adjunctive whole-brain radiation and chemotherapy may negatively impact these critical areas
114,123,124

. Global network considerations of treatment methods may lead to the usage of more

precise radio- and chemo-therapies that could lead to an overall better quality of life 125–127.
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Accounting for areas beyond eloquent cortex may limit the extent of resection, but the cost of
restricted resections must be weighed with postoperative quality of life. Therefore, accumulating
evidence of these treatment and quality of life relationships via future rs-fMRI studies would
lead to more informed persons involved in the decision-making process i.e., neurosurgeons,
neuro-oncologists, patients, and their caregivers.

1.5 Deciphering Glioma-Related Changes Using rs-fMRI
Using rs-fMRI measures to understand the impact of gliomas is still in its infancy 128. The
documented effects of these tumors on brain networks are limited, and the relevance to larger
patient populations is undetermined 128. Current efforts are divided between: (i) improving
eloquent cortex mapping techniques 90,102,129 and (ii) understanding glioma-specific network
changes and their association with patient outcomes 29,130–134. As the focus of this present work is
on the latter, it is important to briefly review the current literature as it sets the stage for the
studies performed.

1.5.1 Glioma-associated network alterations
Despite the heterogeneity within and across gliomas (see Sections 1.2-1.3), many reported rsfMRI studies do not attempt to discriminate between tumor pathology 128. For these studies, it is
difficult to make any claims regarding the effects of specific types/grades of gliomas on brain
function. Moreover, studies have suffered from low patient sample sizes, therefore potentially
precluding the extrapolation of reported effects to the population 128. Nonetheless, investigations
have focused on glioma-induced changes in specific resting-state networks or utilized graph
theory to determine whole-brain network alterations.
Specific networks: Reports have shown location-dependent reductions in the default
11

mode network, a task-negative network associated with introspective cognitive functions and
implicated in certain neurological diseases 135–141. Additionally, interhemispheric connectivity
reductions in the motor network are associated with motor deficits and tumor grade 142–144. In a
language network study, Briganti et al. showed that left hemispheric tumors significantly reduced
global connectivity of language-related brain regions 145.
Graph theory network changes: Studies using graph theory paradigms have reported
widespread functional changes. Derks and colleagues reported increased connectivity between
hub (brain locations with strong connectivity to multiple areas/RSNs) and non-hub areas, while
connectivity between hub areas decreased 29. Hub to non-hub connectivity was also significantly
associated with Karnofsky performance status (KPS; a functional assessment test used by
clinicians and reportedly associated with OS in glioma patients) and progression-free survival
29,146

. Other studies have reported increased local efficiency 147, network robustness 148 and hub

damage-dependent reduction of the brain’s modular structure 107. The latter study included only 4
tumor patients and had other patients with lesions of vastly different etiologies (25 stroke and 6
traumatic brain injury patients). This conflation of pathologies may limit generalizability.
In summary, gliomas appear to elicit widespread functional connectivity disruptions that
impact multiple networks and may relate to particular outcome measures. However, more robust
studies are needed to generalize findings to patient populations.

1.5.2 rs-fMRI to detect tumor spread and cortical tissue changes
Since rs-fMRI uses cerebrovascular/hemodynamic-related fluctuations to infer neuronal activity,
and gliomas alter local vasculature, BOLD signal alterations may localize to the tumor. As
gliomas are highly diffused, this may serve to identify tumor infiltration. One of the first studies
to investigate this relationship showed that in a small heterogeneous patient sample (n = 13),
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tumor areas could be differentiated from normal tissue using BOLD signals 149. However,
although this appeared to recapitulate the T1-weighted tumor mass, they did not quantify the
overlap between them. Furthermore, the work was considered preliminary, and no claims were
made regarding the use of this technique to capture the entirety of tumor infiltration.
Peritumoral regions have been shown to also harbor infiltrative cells and provide
evidence for more aggressive resections 150–153. Therefore, a technique that demarcates tumor
boundaries within the edema would potentially improve surgical resections and improve
outcomes. Using rs-fMRI, a few studies have investigated the relationship between the
peritumoral edema region and the contrast-enhancing tumor volume. Chow and colleagues
showed that the BOLD timeseries of tumor volumes are also correlated with the peritumoral
edema and concluded that this was due to tumor-induced vascular dysregulation 154. In a follow
up study, they identified a correlation between regions highlighted by their abnormal BOLD
signals to tumor cell density, which was confirmed by histology obtained through biopsies 155.
Although this study was limited by the number and location of the biopsies, it suggested that
resting-state analyses have the potential to inform tumor spread. A non-invasive measure of
tumor spread would be a boon to pre-surgical planning as it would lead to more targeted
treatment approaches.
Recent work by Stoecklein et al. and Nenning et al. have extended this work to
investigate local and global glioma-related disruptions133,134. Using an RSN-agnostic technique,
Stoecklein and colleagues found widespread BOLD alterations that were associated with WHO
grade, IDH status, and cognitive performance 133. High-grade gliomas also induced greater
contralesional disruptions. Although the effects of lesion location or the use of non-age-matched
controls to derive their abnormality measure were not accounted for, this study suggested that
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glioma-induced BOLD alterations may serve as a diagnostic biomarker and inform
neurocognition and extent of cortical network dysfunction 135,156,157. In the work by Nenning et
al., whole-brain connectivity disruptions in glioblastoma were also investigated and
demonstrated homotopic alterations 134. Surprisingly, in a subset of patients, the connectivity
anomalies predicted tumor recurrence locations. Although this predictability was limited to gray
matter infiltrated tumors, this again demonstrated a diagnostic role for rs-fMRI. Future studies
are needed to validate these results and investigate additional effects of tumor biology on wholebrain connectivity.

1.5.3 Resting-State fMRI biomarkers for outcome prediction
The goal of developing new glioma treatments is to improve patient outcomes. Therefore, it is
imperative that novel techniques be contrasted with changes in these measures. Towards this
goal, various groups have utilized advanced data-driven approaches with structural MRI to
identify features that have been linked to the genetic variability of tumors, PFS and OS 158–163.
Similarly, it may be possible to identify functional and hemodynamic correlates of patient
outcomes. These findings could complement existing prognostic measures and would be readily
available for clinical implementation.
As mentioned in sections 1.5.1 and 1.5.2, investigations into a correlation between rsfMRI and patient outcomes have begun. Derks et al. demonstrated a relationship between global
connectivity measures, PFS and KPS 29. Nenning and colleagues predicted tumor recurrence
using signal anomalies 134. In the study by Stoecklein et al., global functional connectivity
anomalies were tested for their association to overall survival revealing a correlation of -0.48, but
this was not statistically significant 133. These findings demonstrate the feasibility of using rsfMRI for prognostication.
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Certain groups have also applied machine-learning techniques to rs-fMRI functional
connectivity data to predict overall survival. Liu et al. used graph theory measures derived from
whole brain functional and structural connectivity to train a support vector machine (SVM)
resulting in 75% prediction accuracy when classifying high vs. low overall survival 164. A
follow-up study using least absolute shrinkage and selection operator (LASSO) feature selection
increased accuracy to 86.8% 165. Our lab has also explored binary overall survival classification
of glioblastoma using rs-fMRI 166. We showed that the features from the functional connectivity
matrix were sufficient to predict OS with an accuracy of 71.9%. As these techniques currently
only stratify patients into high or low survival bins, these predictions have a wide range.
Additionally, patients were acquired retrospectively, and no follow-up studies to test the
algorithms using new patients have been performed. Lastly, low sample size and limited
interpretability of the selected features may impact clinical adoption.

1.6 Potential Limitations
As a technique to study brain function, rs-fMRI is not without technical and logistic limitations.
Importantly, these limitations may be more prevalent and have greater consequences in a clinical
population. Furthermore, gliomas may introduce additional confounds that need to be addressed
to improve interpretability and preoperative planning.

1.6.1 Intrinsic limitations of rs-fMRI
Signal loss due to susceptibility artifacts is inherent to fMRI physics 90. Draining veins may also
accentuate these artifacts and alter BOLD signals. Certain acquisition methods can help reduce
these effects 167,168. Although patients do not have to perform tasks for rs-fMRI mapping, they
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still need to comply with simple instructions while in the scanner 79,96. Motion artifacts is one of
the pervasive confounds of rs-fMRI, and patients are usually tasked to remain still either with
eyes closed or fixated on a screen 169,170. It may be difficult for a patient to remain motionless,
therefore comprising the results of the scan. Additionally, BOLD is an inherently noisy signal,
but the signal-to-noise ratio improves if longer scans are done 102,171,172. However, this may
increase patient discomfort and diminish signal quality due to motion.

1.6.2 Glioma-specific limitations
As aforementioned, gliomas alter the local vasculature and can displace the cellular units
responsible for neurovascular coupling. When neurovascular uncoupling occurs, the fundamental
relationship between hemodynamic fluctuations and neural activity is compromised 45,173. This
can lead to interpretability errors and potentially result in the resection of normal healthy tissue if
fMRI mapping approaches indicated no underlying neural activity. As gliomas grow, they induce
peritumoral brain swelling (edema) and mass effect. This can distort brain anatomy and decrease
the BOLD signal. This also complicates the use of functional templates or parcellations for
known brain regions as the underlying parenchyma in adjacent regions may have changed. In
addition to these limitations, patients’ age, physiological state, and active medications may all
affect the BOLD signal 90. Therefore, an awareness of these factors can help improve study
design and elucidations.

1.7 Summary
Gliomas are destructive brain tumors with a cellular and molecular arsenal that makes current
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therapies ineffective. Ongoing investigations are tackling this behemoth from multiple angles to
seek improvements in patient care. From a preoperative standpoint, the quest for novel,
noninvasive biomarkers is attractive as neurosurgeons and neuro-oncologists seek to maximize
overall survival and quality of life using all the information at their disposal. Therefore, there is a
critical need for more in-depth analyses of existing methods as well as novel techniques to
determine glioma effects on the networked brain to obtain clinical correlates that can improve
outcomes. Use of rs-fMRI to identify these biomarkers is a practical, readily available
technology that is less taxing on patients, provides whole brain mapping, and produces signals
appreciably altered by tumors, thus potentially enabling patient specificity.

1.8 Organization of the Dissertation
This thesis utilizes the principles of rs-fMRI and glioma-brain interactions to critically
investigate the impact of gliomas on specific aspects of functional connectivity and to determine
whether these effects have prognostic value. Since we were not confined to eloquent cortex, we
first examined the prevalence of functionally connected regions within glioblastoma, its
relationship to tumor morphology, and implications for overall survival (Chapter 2). We then
explored the influence of tumor biology on interhemispheric functional connectivity using the
well-established principle of homotopic connectivity and tested how these extra-tumoral
connections influenced survival (Chapter 3). Finally, in Chapter 4, we discuss the implications of
these results and explore potential avenues to expand upon these findings.
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Chapter 2: Functional connectivity within
glioblastoma impacts overall survival
This chapter has been adapted from a published journal article. The citation is: Daniel,
A.G.S., Park, K.Y., Roland, J.L., Dierker, D., Gross, J., Humphries, J.B., Hacker, C.D., Snyder,
A.Z., Shimony, J.S., Leuthardt., E.C. Functional connectivity within glioblastoma impacts
overall survival. Neuro-Oncology. 2021, 23 (3), 412-421.

2.1 Abstract
2.1.1 Background
Glioblastoma (GBM; WHO grade IV) assumes a variable appearance on magnetic resonance
imaging owing to heterogeneous proliferation and infiltration of its cells. As a result, the
neurovascular units responsible for functional connectivity (FC) may exist within gross tumor
boundaries, albeit with altered magnitude. Therefore, we hypothesize that the strength of
functional connectivity within GBMs is predictive of overall survival.

2.1.2 Methods
We used pre-defined FC regions of interest (ROIs) in de novo GBM patients to characterize the
presence of within-tumor FC observable via resting-state fMRI and its relationship to survival
outcomes.

2.1.3 Results
57 GBM patients (mean age 57.8 ± 13.9 years) were analyzed. Functionally connected voxels,
not identifiable on conventional structural images, can be routinely found within the tumor mass
and was not significantly correlated to tumor size. In patients with known survival times (n =
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31), higher intra-network FC strength within GBM tumors was associated with better overall
survival even after accounting for clinical and demographic covariates.

2.1.4 Conclusions
These findings suggest the possibility that functionally intact regions may persist within GBMs
and that the extent to which FC is maintained may carry prognostic value and inform treatment
planning.

2.2 Introduction
Glioblastoma multiforme (GBM) is a highly infiltrative and deadly form of brain cancer 1,2.
Given the heterogeneous nature of this disease, its distribution within brain parenchyma is
extremely variable. It is clear that tumor growth results in death of surrounding tissue and
displacement of native cells. However, limited evidence suggests that functionally intact brain
tissue may be preserved within the tumor boundaries 3–5. Most of this evidence has been derived
by intraoperative direct stimulation of sensorimotor and language areas, i.e., eloquent cortex 3–6.
This mode of inquiry neglects cognitive processes such as attention, executive function, and
planning that are not easily assessed in the operating room 7,8. These functions are relevant to
patient outcomes; hence, their neglect during pre-surgical planning may lead to compromised
patient well-being and overall survival 9–11. Moreover, prior studies of preserved intra-tumor
function have been limited by small sample sizes. Accordingly, drawing population inferences
regarding survival in patients with brain tumors in general and glioblastoma in particular has
been challenging.
Task-based functional magnetic resonance imaging (T-fMRI) is routinely employed
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during pre-surgical planning of tumor resections 12–14. More recently, resting-state fMRI (rsfMRI) has been used as an alternative technique for functional mapping with several advantages
over task-based fMRI. For instance, rs-fMRI can be acquired in patients that are unable to
cooperate with a task, such as young children or patients that are cognitively impaired 15–17. The
rs-fMRI method relies on identification of temporally correlated, intrinsic fluctuations of infraslow blood-oxygen-level-dependent (BOLD) signals, i.e., functional connectivity (FC). The
associated topographies are widely known as resting-state networks (RSNs). RSNs correspond to
functional systems instantiating attention, executive control, and episodic memory, in addition to
motor and language function 18. Motor and language maps derived by rs-fMRI have shown good
correspondence with results obtained with stimulation mapping and task-based fMRI 19,20.
Several rs-fMRI studies have identified network specific changes in patients with brain tumors
but sample sizes were small and tumor pathologies heterogeneous 21. The possibility of preserved
GBM intratumor function has so far not been addressed using rs-fMRI.
We acquired rs-fMRI in 57 de novo GBM patients prior to surgery and evaluated
intratumor functional connectivity of several RSNs. We tested the hypothesis that the magnitude
of this connectivity is associated with overall survival. Our data show that the strength of
intratumor functional connectivity is an independent predictor of survival. Thus, rs-fMRI has
potential prognostic value in GBM patients.

2.3 Methods
2.3.1 Subjects
Fifty-seven patients with new primary glioblastoma multiforme (GBM) underwent evaluation
prior to surgical resection. Patients were recruited from the neurosurgery brain tumor service,
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initially as part of a National Institutes of Health (NIH)–funded tumor database grant (NIH
5R01NS066905). All aspects of the study were approved by the Washington University in St.
Louis (WUSTL) Institutional Review Board and the clinical data were retrospectively reviewed.
The following inclusion criteria were used: new diagnosis of primary brain tumor; age more than
18 years; and clinical need for a magnetic resonance imaging (MRI) scan, including rs-fMRI as
determined by the treating neurosurgeon. Exclusion criteria included prior surgery for brain
tumor, inability to have an MRI scan, and patients referred from an outside institution with an
MRI scan performed without rs-fMRI.
For control analyses, clinically healthy adult data (n = 100 subjects) was obtained from
the Harvard-MGH Brain Genomics Superstruct Project (GSP). This dataset is described in Yeo
et al., 201122. Adult participants provided written informed consent in accordance with the
guidelines set by the institutional review boards of Harvard University and Partners Healthcare.

2.3.2 MRI Acquisition
Data was acquired using a Siemens 3T Trio or Skyra MRI scanner. Patients were scanned using
a standard clinical presurgical tumor protocol. Anatomic imaging included T1-weighted (T1w)
magnetization prepared rapid acquisition gradient echo (MPRAGE), T2-weighted (T2w) fast
spin echo, fluid attenuated inversion recovery (FLAIR) imaging, and post-contrast T1w fast spin
echo in 3 projections. The rs-fMRI was acquired using an echo planar imaging sequence (voxel
size = 3 mm cubic; echo time (TE) = 27 ms; repetition time (TR) = 2.2-2.9 s; field of view = 256
mm; flip angle = 90°) for a total of 320 frames. For the GSP subjects, the data was acquired as
described by Yeo et al. (2011) briefly summarized here: the data were collected on Siemens Trio
3T scanners (Erlangen, Germany) using a 12-channel phased-array head coil. The structural data
was acquired using a high-resolution multi-echo T1w MPRAGE sequence. The rs-fMRI was
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collected using a gradient-echo echo planar imaging sequence (voxel size = 3 mm cubic; TE =
30 ms; TR = 3000 ms; field of view = 216 mm; flip angle 85°). Two BOLD runs were acquired
per subject with 124 frames per run (6.2 min).

2.3.3 MRI Pre-processing
Preprocessing procedures used standard approaches as previously described 16,19. This included
compensation for slice-dependent time shifts, removal of systemic odd-even slice intensity
differences due to interleaved acquisition, and rigid body correction for head movement within
and across runs. Atlas transformation was achieved by composition of affine transforms
connecting the functional imaging volumes with the T2-weighted and T1-weighted structural
images, resulting in a volumetric time series in isotropic 3 mm3 atlas space. Additional
preprocessing included spatial smoothing (6 mm full-width half-maximum Gaussian blur in each
direction), voxel-wise removal of linear trends over each run, and temporal low pass filtering
retaining frequencies less than 0.1 Hz. Spurious variance was reduced by regression of nuisance
waveforms derived from head motion correction and extraction of the time series from regions of
white matter and cerebrospinal fluid. The whole-brain (global) signal was included as a nuisance
regressor. Frame censoring was performed to minimize the impact of head motion on the
correlation results. Thus, frames (volumes) in which the root mean square (evaluated over the
whole brain) change in voxel intensity relative to the previous frame exceeded 0.5% (relative to
the whole-brain mean) were excluded from the functional connectivity computations.

2.3.4 Tumor segmentation
Using the software application ITK-SNAP 23, brain tumors were segmented semi-automatically
using multimodal image acquisitions (T1w, postcontrast T1w, T2w and FLAIR). This enabled
the separation of contrast-enhancing tumor, necrosis and surrounding FLAIR hyper-intense
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edematous areas from normal cortical and subcortical tissue. Tumor was defined as contrastenhancing plus necrotic-appearing regions.

2.3.5 Resting-state network identification
Based on 24, 169 ROIs throughout the brain were selected with each ROI belonging to one of
seven canonical resting-state networks. Using the segmented contrast-enhanced bounded tumor
and the peritumor FLAIR hyperintense “edema” regions as masks, the ROIs found within those
areas were identified (Figure 2.1C). To create a timeseries for each resting-state network, the
voxels within each network-specific ROI outside of the tumor and peritumor regions (i.e., extratumor regions) were averaged together. Using Pearson correlation, the network BOLD timeseries
were then correlated with their corresponding network ROIs found within the tumor to obtain the
intra-network connectivity strength for that ROI. Additionally, the BOLD timeseries of each
network was Pearson correlated with the timeseries for each voxel found within the tumor (i.e.
intratumor) to identify the correlation strength of each voxel to every network. Computed
correlations were Fisher z-transformed. A conservative threshold of r > 0.3 was taken as
indicating the presence of functional connectivity of a voxel to a particular network 25. Each of
the 100 controls in the GSP dataset was treated identically to every GBM patient. Patient-derived
tumor and peritumor masks were used to create virtual tumor and peritumor regions. Seed-based
functional connectivity then was computed in each control.

2.3.6 Statistical Analysis
Statistical analyses were performed in Excel (Microsoft Corporation, Redmond, Washington), R
(R Foundation for Statistical Computing, Vienna, Austria), Prism (GraphPad, San Diego,
California) and MATLAB (2017b, Natick, Massachusetts). The log-rank test was used to
compare Kaplan-Meier survival curves of intratumor connectivity derived via ROIs and voxel-
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wise (n=31). Bonferroni correction was applied to correct for multiple comparisons.
Additionally, univariate and multivariate Cox regressions were employed to compare the effects
of covariates (age, tumor volume, Karnofsky Performance Score (KPS), intratumor ROI intranetwork connectivity, intratumor voxelwise network connectivity) on survival. The patients
evaluated by Cox regression were IDH wild-type (n=31). A p-value of 0.05 indicated statistical
significance.

2.4 Results
2.4.1 GBM intratumor functional connectivity is identifiable in most patients
A total of 57 patients (15 females, 42 males) with a histological diagnosis of de novo GBM were
retrospectively identified (Table 2.1). The average age was 57.8 ± 13.9 years with a range of 21
to 83 years. Most patients had either a partial (n=27) or gross total (n=25) resection followed by
chemotherapy and radiation. Heterogeneity of GBM location, size and morphology is illustrated
in Figure 2.1A. Figure 2.1B shows heatmaps representing the distribution of tumor density (as
defined by contrast-enhanced T1-weighted boundaries) in the present patient sample. GBMs
were approximately evenly distributed in the left (29 patients) and right (22 patients)
hemispheres. Tumor involvement was bilateral in 6 (11%) patients. Genetic studies were
performed in most cases (Table 2.1). These studies included O[6]-methylguanine-DNA
methyltransferase (MGMT) promoter methylation, isocitrate dehydrogenase-1 R132 (IDH-1)
mutation and epidermal growth factor receptor (EGFR) amplification. 23 out of 54 patients
whose status was recorded (42.6%) showed MGMT methylation; only 5 out of 56 had confirmed
IDH-1 mutations (8.9%); 17 out of 37 were positive for EGFR amplification (44.7%).
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Table 2.1 Demographic, clinical, and molecular characteristics of GBM patients.
Summary Of Characteristics
No. of patients

57

Mean age in years

57.8 ± 13.9 (21.4-83.4)

(range)
Sex
Male

42

Female

15
3

39.5 ± 34.9

CE volume (cm )
3

FLAIR volume (cm )

116.0 ± 73.0

KPS, n (%)
>70%

24 (42)

Missing

3

Extent of resection
Gross-total

25

Subtotal

27

Biopsy

1

Laser

4

MGMT status
Methylated

23

Non-methylated

31

Missing

3

IDH mutation
Mutated

5

Wild type

51

Missing

1

EGFR Amplification
Positive

17

Negative

21

Missing

19

Resting-state time series were extracted from a set of 169 regions of interest (ROIs)
belonging to 7 canonical RSNs defined in atlas space (Figure 2.1C) 24. ROI-based and voxel-
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based measures were used to evaluate the prevalence and variability of intratumor FC (see
Materials and Methods). The patient FC measures were compared to control FC measures
derived from 100 normal young adults in the Harvard-MGH Brain Genomics Superstruct Project
(GSP) dataset 22. The patient and control data were analyzed identically with "tumor boundaries"
in the controls duplicated from those in the patients. Findings using the contralesional mirror site
as a control ROI were obtained in a subset of patients (n = 35) (see SI Methods and Figure
S2.1).

Figure 2.1 Intratumor functional connectivity in GBM patients. (A) Post contrast T1w images in
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a sample of 8 patients. (B) Heat maps showing the distribution of tumor density in the full
sample of 57 patients. (C) Schematic of ROIs used to determine network affiliation. rs-fMRI
time series were averaged over ROIs outside the tumor to define RSN-specific timeseries.
Correlation of these time series against intra-tumor ROIs yielded assessment of intra-tumor FC.
VIS: visual network; DAN: dorsal attention network; SMN: sensorimotor network; VAN: ventral
attention network; LAN: language network; FPC: fronto-parietal control network; DMN: default
mode network.

93% of GBM patients had at least one intratumor ROI. Averaging over patients, the mean
number of intratumor ROIs per RSN ranged from 0.40 to 2.44. The distribution of intratumor
ROI-based FC strengths (Fisher z-transformed Pearson correlation) was approximately zerocentered in the patients (Figure 2.2A). In contrast, the same quantity in the control population
was centered around 0.5 (Figure 2.2B). No RSN specificity of intratumor FC was apparent in
either group. For all RSNs, the mean “intratumor” FC in the controls was significantly different
from zero (one-sample t-test, p < 0.0001) and significantly different from the corresponding
network in GBM patients (two-sample rank sum test, p < 0.00001). ROI-based intratumor FC
distributions, collapsed over RSNs, are shown in Figure 2.2C-D for the patients and controls,
respectively. Systematically lower FC in tumor ROIs is expected (GBM patients mean: 0.048 vs.
0.52 in controls, unpaired t-test, p<0.00001). In principle, FC in non-functional tissue should be
narrowly distributed about zero (Figure S2.2). Instead, the patient and control distributions were
comparably wide, although a small, but statistically significant, difference was found between
the FC distribution standard deviations of the patients and controls (GBM patients: 0.24 vs.
Controls: 0.28; F-test, F= 0.7414, p< 0.0001). The mean FC within patient intratumor ROIs was
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statistically greater than zero (one-sample t-test, p<0.0001) with a larger standard deviation than
expected by chance (GBM patients: 0.24 vs. Null distribution: 0.08; F-test, F = 0.1137,
p<0.0001, see Fig. S2).

Figure 2.2 ROI-based functional connectivity (Fisher z-transformed correlation) within GBMs.
(A) FC in GBM patients (n=53). FC strength is represented as a boxplot corresponding to
assigned network. The mean of the VIS, DAN, FPN and DMN FC distributions were not
significantly different from zero (one sample t-test, p >0.05). However, in some patients, some
ROIs had FC values of 0.5 or greater. (B) Virtual intratumor FC in controls. Each control
41

(n=100) was treated as every GBM patient (n=53) to obtain the expected connectivity strengths
and overall intranetwork distributions for the ROIs found within the tumor masks of each GBM
patient. The median of every network in controls was greater than its corresponding distribution
in GBM patients (two-sample Wilcoxon rank sum-test, p<0.00001). (C) Intratumor FC
distribution in GBM patients, collapsed over RSNs. The mean of this distribution is significantly
greater than zero (one-sample t-test, p < 0.0001). (D) Virtual intratumor FC distribution in
controls. The mean of this distribution is ~0.5. The control FC distribution is smoother because it
represents a larger sample of “intratumor” ROIs.

The observation of occasionally significant intratumor FC prompted us to investigate the
topography of this phenomenon. Six representative patients are illustrated in Figure 2.3A.
Voxels in which FC with any of the seven canonical RSNs exceeded 0.3 (operationally defined
as “functionally connected”) are shown in green. This criterion is arbitrary but it provides a basis
for comparisons across patients. Functionally connected voxels were very unevenly distributed
across patients (Figure 2.3B). At least one such voxel was present in 98.3 % of patients (n = 56).
In most patients (n = 29), such voxels accounted for less than 20% of the tumor mass. More than
half of the tumor mass met this criterion in only 7% of patients (n = 4). Functionally connected
voxels tended to occur in clusters but otherwise no characteristic distribution, e.g., tumor core vs.
periphery, was evident on visual inspection. Quantitatively, a greater proportion of functionally
connected voxels was found in contrast-enhanced (CE) areas compared to necrotic (NEC)
regions (CE mean = 0.78 vs. NEC mean = 0.22; unpaired t-test, p< 0.0001, Figure 2.3C). The
fraction of functionally connected voxels was slightly greater in small vs. large tumors (Figure
2.3D) although this relation was not statistically significant by formal regression analysis (R2 =
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0.0322, p = 0.182).

Figure 2.3 Voxelwise identification of intratumor function. (A)Post-contrast T1w slices and
corresponding intratumor FC maps of 6 GBM patients demonstrate tumor and intratumor FC
heterogeneity. Green denotes voxels that were assigned FC after obtaining a correlation r > 0.3
with at least one resting-state network. Beige denotes voxels that did not meet this criterion (no
FC). (B) Distribution of the percentage of intratumor FC voxels by number of patients reveals
that most patients have a low proportion of functional voxels. (C) Bar chart showing the
proportion of FC voxels in contrast-enhanced (CE) and necrotic (NEC) areas in GBM tumors (n
= 56). Error bars denote 95% CI. CE regions demonstrate significantly higher proportion of FC
than NEC areas (CE = 0.78 vs. NEC = 0.22, unpaired t-test, p< 0.0001). (D) Plot of percentage
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of intratumor FC voxels versus tumor volume demonstrating no significant correlation (p =
0.182).

2.4.2 Strength of GBM intratumor functional connectivity in relation to
survival
Heterogeneity of intratumor FC across patients raises the possibility that this measure may relate
to survival. To examine this possibility, we analyzed the available data in all patients with
intratumor ROIs and known survival times (interval between diagnosis and death; n = 31, Table
S2.1). This analysis was conducted using both ROI-based and voxel-based intratumor FC
measures. In both cases, the patients were median split into Low FC and High FC groups and
survival data were compared using the Wilcoxon rank sum test and Kaplan-Meier survival
analysis.
The ROI-based FC measure was evaluated as the median intra-network FC over all
intratumor ROIs. Median survival in the High FC group (15.51 months) was significantly longer
than that in the Low FC group (8.35 months) (right-tailed Wilcoxon rank sum, W= 204, p
<0.001, Bonferroni corrected) (Figure 2.4A). Similarly, Kaplan-Meier analysis demonstrated a
significant difference in survival (log-rank test, p < 0.001, Bonferroni corrected)(Figure 2.4B).
For the voxelwise analysis, each intratumor voxel was assigned a value equal to the
maximum FC over the 7 canonical RSNs. The voxel-based FC measure then was evaluated as
the median intra-network FC over all the voxels in each patient’s tumor. Median survival times
for the High FC and Low FC groups were 14.1 months and 10.5 months, respectively. This
difference was not significant (right-tailed Wilcoxon rank sum, W = 281, p = 0.11, Bonferroni
corrected). Similarly, the Kaplan-Meier analysis showed a modest difference in survival times
(longer survival in the High FC group by log-rank test, p = 0.084, Bonferroni corrected) (Figure
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2.4C).
Multivariate Cox regressions were performed to control for potential influences of
clinical and demographic covariates, e.g., performance status, on survival times (Table 2.2).
Patients with high postoperative Karnofsky Performance Status (KPS >70) had longer survival
times (HR: 0.31, 95% CI: 0.012-0.82, p = 0.018), in accordance with previously reported results
26

. The ROI-based FC measure remained prognostic of overall survival after inclusion of

demographic covariates (HR: 0.29, 95% CI: 0.12-0.66, p = 0.0035). The range of effect sizes was
similar for intratumor ROI-based FC and KPS but intratumor FC was a stronger predictor of
survival. Univariate Cox regression showed that intratumor voxelwise FC was a significant
predictor of survival and this effect was maintained with inclusion of age, tumor size and KPS as
covariates (HR: 0.33, 95% CI: 0.13-0.84, p = 0.021).
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Figure 2.4 Intratumor functional connectivity stratifies overall survival in GBM patients. (A)
ROI derived FC: Overall survival in GBM patients with low intratumor FC are compared to
patients with high intratumor FC. Asterisk indicates significant difference (right-tailed Wilcoxon
rank sum, W = 240, p <0.001, Bonferroni corrected). (B) ROI derived FC: Kaplan Meier
survival analysis comparing overall survival in low intratumor FC GBM patients and high FC
patients. Patients with high intratumor FC had a significantly longer overall survival than those
with low intratumor FC (HR: 0.25, 95% CI: 0.11-0.58, p =0.0011). (C) Voxel-wise derived FC:
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Overall survival in GBM patients with low intratumor functional connectivity (FC) are compared
to patients with high intratumor FC (right-tailed Wilcoxon rank sum, W = 281, p =0.11,
Bonferroni corrected). (D) Voxel-wise derived FC: Kaplan Meier survival analysis comparing
overall survival in low intratumor FC GBM patients and high FC patients. Patients with high
intratumor FC had a significantly longer overall survival than those with low intratumor FC (HR:
0.45, 95% CI: 0.21-0.98, p = 0.044).

Table 2.2 Univariate and multivariate survival analysis
Characteristic

Univariate Cox
HR
(95% CI)

p value

Multivariate Cox
(ROI FC)
HR
(95% CI)

p value

Multivariate Cox
(VW FC)
HR
(95% CI)

p value

Age at initial
Diagnosis

1.01
(0.96,1.05)

0.84

0.996
(0.96, 1.03)

0.79

0.97
(0.93, 1.02)

0.25

CE volume
(cm3)

1.02
(1.01,1.03)

0.0038

1.02
(1.01, 1.03)

0.0044

1.02
(1.01, 1.04)

0.00095

KPS >70

0.33
(0.13,0.84)

0.02

0.31
(0.12, 0.82)

0.018

0.35
(0.13, 0.92)

0.034

Intratumor FC
(ROI) = High

0.25
(0.11,0.58)

0.0011

0.29
(0.12, 0.66)

0.0035

Intratumor FC
(VW) = High

0.45
(0.21, 0.98)

0.044

0.33
(0.13, 0.84)

0.021

2.5 Discussion
It has been reported that functional brain tissue exists within GBM tumors 3–5. Evidence speaking
to this question has so far been limited by functional scope (i.e., a focus on eloquent cortex) as
well as study parameters (i.e., low sample size and heterogeneous tumor pathology). Here, we
used rs-fMRI in 57 newly diagnosed GBM patients to non-invasively assess resting state
functional connectivity (FC) within tumor boundaries. Intratumor FC was evaluated in
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conformity with priors derived from a large sample of normal individuals 24. Mean FC within
tumor boundaries was significantly greater than zero (Figure 2.2C-D). Importantly, this measure
was remarkably variable over patients (Figure 2.3B). Moreover, high intratumor FC was
associated with longer survival (Figure 2.4).
Some fraction of FC variability is attributable to measurement error 27. Variable intrinsic
activity organization (in extra-tumor tissue) present in all individuals may also contribute 28,29.
Nevertheless, the nearly equal widths of the tumor and control FC distributions is somewhat
surprising (Figure 2.2C-D, Figure S2.1C-D). Inter-individual differences in the extent of
preserved physiology is the most plausible explanation for the finding in question. The survival
results are consistent with this view: tumors with more preserved physiology carry a more
favorable prognosis.
GBM tumors characteristically are histologically heterogeneous as well as infiltrative
31,32

. We observed intratumor FC in contrast enhancing regions as well as hypointense, non-

contrast enhancing regions commonly thought of as necrotic. In principle, functional
connectivity should not exist within truly necrotic (non-viable) tissue. However, recent work
suggests that high cellularity may be present within regions that appear to be necrotic by MRI 33.
Thus, it is plausible that neuropil retaining some degree of functional connectivity may be
intermixed with non-functional tumor cells, as illustrated in Figure 2.3A. The low proportion of
functionally connected voxels found within necrotic regions also supports this notion (Figure
2.3C). Moreover, in our data, the fraction of "functionally connected" voxels was only weakly
related to tumor volume (Figure 2.3D). This observation also is consistent with the highly
infiltrative nature of GBMs.
The survival results shown in Figure 2.4 suggest that loss of intratumor FC is a marker of
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more advanced and/or more aggressive tumors. The simplest explanation for this finding is that
tumor growth causes progressive destruction of functioning neural tissue 2. Alternatively,
attenuated FC could result from impaired neurovascular coupling 34. More elaborate possibilities
are suggested by recent work demonstrating that glioblastoma cells form synapses with neurons
that interfere with normal excitability and promote invasion 35,36. The present data cannot
distinguish between any of these pathophysiological mechanisms. Thus, although the present
results do suggest that retained FC within GBM tumors has positive prognostic value, this
observation remains empirical.
A final point that bears discussion is the distinction between evoked vs. intrinsic BOLD
fMRI signals, the latter of which constitutes the basis of resting state FC. In the context of
presurgical mapping, T-fMRI responses typically appear approximately where expected, outside
the tumor (allowing for shifts owing to mass effect) but not inside the lesion; not uncommonly,
such responses abruptly truncate at the lesion boundary 17,37,38. Thus, there would seem to be
little reason to expect intrinsic BOLD signal fluctuations inside GBM tumors, notwithstanding
that sensory and motor responses to direct electrical stimulation over GBM tumors are well
documented 3,4. The apparent discrepancy between T-fMRI and rs-fMRI is procedural: The
objective of T-fMRI is to localize the representation of function outside the tumor with the
objective of sparing functional tissue during surgery. In standard practice, no effort is made to
detect or display weak T-fMRI responses inside the tumor. Here, in contrast, the analysis is
explicitly focused on intra-tumor voxels, which, on the whole, showed weak evidence of FC with
parts of the brain outside the tumor. Statistical analysis revealed that the prevalence of intratumor
FC varied widely over patients and this variability carried prognostic value. However, it is
unlikely that the "functionally connected" parts of GBM tumors contribute to on-line behavior.
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Indeed, we tested this possibility in our patients and found that Karnofsky Performance Status
was unrelated to intratumor FC metrics (both ROI-based and voxel-based), controlling for age
and tumor volume (Table 2.2).
Intratumor FC measures may distinguish patients during the treatment planning phase
enabling neurosurgeons, oncologists, and patients to be more informed prior to surgery. First and
foremost, improved prognostication of a given patient’s likely outcome following diagnosis
would enable the patient to make more informed decisions regarding their therapeutic options.
As an example, connectivity metrics suggesting a poor prognosis would imply that less
aggressive surgery is warranted to preserve function during the limited time the patient has left.
Conversely, connectivity metrics suggesting a good prognosis might imply that a more
aggressive surgical approach is warranted in order to delay recurrence. These findings may also
help in selecting and stratifying patients for clinical trials. However; further studies will be
required to evaluate how consistent these findings are in the larger GBM population.
In summary, this study demonstrates that functionally connected brain tissue, as defined
by rs-fMRI, is present in the substantial majority of glioblastoma patients. Further, the strength
of functional connectivity within the tumor has prognostic value. Thus, rs-fMRI as a potential
radiological prognostic indicator requires further study.
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2.9 Supplemental Methods
2.9.1 Ipsilesional and Contralesional Intratumor FC comparisons
Inclusion criteria included patients with unilateral GBM lesions and normal appearing
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contralesional hemispheres (n = 35). ROIs close to the midline (n = 19) were removed from the
original set (n = 169). Using the segmented contrast-enhanced bounded tumor and the peritumor
FLAIR hyperintense “edema” regions as masks, the ROIs found within those areas were
identified. To create a timeseries for each resting-state network, the voxels within each
ipsilesional network-specific ROI outside of the tumor and peritumor regions (i.e., extra-tumor
regions) were averaged together. Using Pearson correlation, the network BOLD timeseries were
then correlated with their corresponding network ROIs found within the tumor to obtain the
intra-network connectivity strength for that ROI. The mirroring site of each tumor was treated as
a control by correlating the ROI timeseries found within that region to the corresponding
network-specific contralesional mean ROI timeseries outside. Acquired correlations were
Fisher’s z transformed.

2.9.2 Null distribution
The censored frames for the extratumoral RSN timeseries (n = 466) used to obtain intratumor FC
(Figure 2.2A, Figure 2.2C) were linearly interpolated to equate their lengths (n = 320 frames).
Random Gaussian timeseries (n = 466; 320 frames) were created and temporal low pass filtering
was performed to retain frequencies less than 0.1 Hz. Each random timeseries was paired to an
extratumoral RSN timeseries and correlated pairwise. Each pairing was permuted 1000 times and
acquired correlations were Fisher’s z transformed.

2.10 Supplemental Table
Table S2.1. Demographic, clinical, and molecular characteristics of GBM patients used for
survival analysis (n = 31)
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Summary Of Characteristics
No. of patients
31
Mean age in years
61.4 ± 10.2 (27.9 (range)
80.8)
Sex
Male
23
Female
8
3
39.2 ± 32.2
CE volume (cm )
3
103.8
± 63.2
FLAIR volume (cm )
KPS, n (%)
>70%
10 (32)
Missing
0
Extent of resection
Gross-total
11
Subtotal
20
Biopsy
0
Laser
0
MGMT status
Methylated
9
Non-methylated
22
Missing
0
IDH mutation
Mutated
0
Wild type
31
Missing
0
EGFR Amplification
Positive
10
Negative
11
Missing
10
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2.11 Supplemental Figures

Figure S2.1. ROI-based FC within unilateral GBMs and contralesional controls. (A) FC in GBM
patients (n = 35). FC strength is represented as a boxplot corresponding to assigned ipsilesional
network. (B) Virtual intratumor FC in contralesional controls. The ROIs found in the mirroring
site of the tumor in each patient were correlated to the corresponding network timeseries
generated using contralesional ROIs outside of the virtual tumor. With the exception of FPN
(unpaired t-test, p = 0.14), the mean of every network in the contralesional hemisphere was
greater than its corresponding distribution within GBM tumors (unpaired t-test, p<0.05). (C)
Intratumor FC distribution in GBM patients, collapsed over RSNs. The mean of this distribution
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is significantly greater than zero (one-sample t-test, p < 0.0001). (D) Virtual intratumor FC
distribution in contralesional controls. The mean of this distribution is ~0.3. No statistically
significant differences were found between the standard deviations of the two distributions
(Ipsilesional GBM: 0.25 vs. Contralesional Control: 0.24; F-test, F= 1.14, p = 0.32).

Figure S2.2. Comparing GBM and Null intratumor FC distributions. Blue: Null distribution of
intratumor FC. Filtered (<1 Hz) Gaussian random noise was permuted (1000 times) and
correlated to the extratumoral ROI timeseries found in each patient (n=53) and Fisher’s z
transformed. The distribution mean was not significantly different from zero (one-sample t-test,
p = 0.3) with a range of -0.35 to 0.36. Red: Normalized GBM intratumor FC distribution from
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Figure 2.2C. The mean FC was statistically greater than zero (one-sample t-test, p<0.0001) with
a larger standard deviation than expected by chance (GBM distribution: 0.24 vs. Null
distribution: 0.08; F-test, F = 0.1137, p<0.0001).
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Chapter 3: Severity of homotopic functional
connectivity disruptions in glioma patients is
associated with tumor biology and overall
survival
3.1 Abstract
3.1.1 Background
Gliomas exhibit widespread bilateral functional connectivity (FC) alterations that have been
shown to be associated with tumor grade. Limited studies have examined the specific
connection-level mechanisms responsible for these effects. Given the typically strong FC
observed between mirroring or homotopic brain regions in healthy subjects, we hypothesized
that homotopic connectivity (HC) is altered in low-grade and high-grade glioma patients and the
extent of disruption is associated with tumor grade and predictive of overall survival in a cohort
of de novo high-grade glioma (World Health Organization [WHO] grade IV) patients.

3.1.2 Methods
We used a mirrored FC-derived cortical parcellation to extract blood-oxygen-level-dependent
(BOLD) signals and to quantify FC differences between homotopic pairs in normal-appearing
brain in a retrospective cohort of glioma patients and healthy controls.

3.1.3 Results
Fifty-nine glioma patients (WHO grade II, n = 9; grade IV = 50; mean age, 57.5 years) and
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thirty healthy subjects (mean age, 65.9 years) were analyzed. High-grade glioma patients showed
consistently lower HC compared to low-grade glioma patients and healthy controls across
several cortical locations and resting-state networks. Connectivity disruptions were also strongly
correlated with hemodynamic lags between homotopic regions. Finally, in high-grade glioma
patients with known survival times (n = 42), HC in somatomotor and dorsal attention networks
was significantly correlated with overall survival.

3.1.4 Conclusions
These findings demonstrate an association between tumor grade and HC alterations that may
underlie global FC changes and provide prognostic information.

3.2 Introduction

The tumor burden on glioma patients extends beyond the proximal effects caused by the
macroscopic lesion as tumor cells can be found throughout the cortex1,2. Moreover, given the
highly connected nature of the brain, local changes in the tumor microenvironment can illicit
subsequent functional changes in seemingly healthy regions3,4. These distal effects have been
observed using resting-state functional MRI (rs-fMRI), which utilizes the fluctuations in bloodoxygen-level-dependent (BOLD) signals to identify brain regions that are temporally
correlated3,4. This process, termed functional connectivity (FC), can reveal the network similarity
of spatially noncontiguous brain areas, allowing for their study in healthy and diseased brains5–9.
Few studies have focused on the global cortical impact of glioma using FC3,4,10,11. However,
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recent studies have demonstrated bilateral FC disruptions in glioma patients. Whole-brain FC
alterations were shown to be related to underlying tumor biology and cognitive impairments,
with higher grade glioma resulting in greater deficits3. One study suggested that FC changes in
resting-state networks are due to local within-network damage, but this remains poorly
understood4.
Defining alterations in interhemispheric connectivity may provide critical insights into
the underlying mechanisms resulting in FC disruptions found in glioma patients. For example,
traditional postmortem tract-tracing animal studies and diffusion-weighted MRI studies have
shown a large proportion of callosal fibers interconnecting mirroring (i.e., homotopic) regions of
the cortex12,13. Furthermore, EEG and resting-state FC studies have revealed bilateral functional
relationships with high temporal synchrony between spontaneous fluctuations of BOLD signals
in homotopic areas5,14,15. Although such activity varied in strength by cortical area (e.g., primary
vs association areas), homotopic connectivity [HC] is remarkably consistent across healthy
subjects and is altered with the surgical disconnection of the corpus callosum and cortical lesions
16–18

. However, few studies have investigated the impact of gliomas on homotopic connections19.

Glioma-induced disruption of homotopy is supported by bilateral FC changes seen in the
presence of unilateral glioma (insert Stoecklein). Specifically, because increasing tumor grade
has been associated with increasing whole-brain FC disruptions, impaired HC in glioma patients
is also likely to be dependent on tumor biology3.
Here, we investigated the relationship between glioma grade and HC. We hypothesized
that glioma patients have reduced HC compared to healthy controls and that high-grade gliomas
would be more impacted than low-grade gliomas. As other studies have shown that brain lesions
may induce hemodynamic lags that disrupt FC8,20,21 , we decided to investigate whether
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homotopic lags would impact HC. Additionally, as high HC is a common feature of normal brain
function, we hypothesized that its impairment is associated with overall survival16,22,23. Taken
together, this work highlights the critical importance of HC in understanding the global nature of
brain dysfunction in glioma patients and its impact on survival.

3.3 Methods
3.3.1 Subjects
Patients were retrospectively recruited from the neurosurgery brain tumor service, initially as
part of a National Institutes of Health (NIH)–funded tumor database grant (NIH
5R01NS066905). All aspects of the study were approved by the Washington University in St.
Louis (WUSTL) Institutional Review Board and the clinical data was retrospectively reviewed.
Fifty patients with unilateral primary high-grade glioblastoma multiforme (GBM) and nine
patients with low-grade glioma (LGG) underwent evaluation prior to surgical resection. The
following inclusion criteria were used: diagnosis of primary brain tumor; age more than 18 years;
and clinical need for a magnetic resonance imaging (MRI) scan, including rs-fMRI as
determined by the treating neurosurgeon. Exclusion criteria included prior surgical resection for
brain tumor, prior radiation or chemotherapy, inability to have an MRI scan, and patients
referred from an outside institution with an MRI scan performed without rs-fMRI.
For control analyses, clinically healthy adult data (n = 30 subjects) were obtained from
ongoing studies at the Alzheimer’s Disease Research Center (ADRC) of Washington University
in St. Louis24.
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3.3.2 Image Acquisition and Preprocessing
Structural and functional imaging data were acquired using a Siemens 3T Trio or Skyra
MRI scanner. Patients were scanned using a standard clinical presurgical tumor protocol.
Anatomic imaging included T1-weighted (T1w) magnetization prepared rapid acquisition
gradient echo (MPRAGE), T2-weighted (T2w) fast spin echo, fluid attenuated inversion
recovery (FLAIR) imaging, and post-contrast T1w fast spin echo in 3 projections. The rs-fMRI
was acquired using an echo planar imaging sequence (voxel size = 3 mm cubic; echo time (TE) =
27 milliseconds; repetition time (TR) = 2.2-2.9 seconds; field of view = 256 mm; flip angle =
90°) for a total of 320 frames. For the healthy control subjects, the rs-fMRI scans were collected
using a gradient-echo echo planar imaging sequence (voxel size = 3 mm cubic; TE = 27
milliseconds; TR = 2.2 seconds; field of view = 256 mm; flip angle 90°). Two rs-fMRI runs were
acquired per subject with 164 frames per run (6 min). Preprocessing techniques have been
previously described 9,25. Briefly, this included correction for slice-dependent time shifts,
removal of systemic odd-even slice intensity differences due to interleaved acquisition, and rigid
body correction for interframe head movement. Atlas transformation was achieved by
composition of affine transforms connecting the BOLD volumes with the T2-weighted and T1weighted structural images, resulting in a volumetric time series resampled to 3-mm cubic
voxels. BOLD time series were low-pass filtered to retain frequencies <0.1 Hz, spatially
smoothed with a 6 mm full-width half-maximum Gaussian kernel, linear trends over each run
were removed voxel-wise. Nuisance regressors included waveforms derived from head
movement correction, white matter, cerebrospinal fluid, and the whole-brain (global) signal.
Frame censoring was performed to minimize head motion effects. Frames in which the root
mean square (evaluated over the whole brain) change in voxel signal intensity relative to the
previous frame exceeded 0.5% (relative to the whole-brain mean) were excluded from the FC
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calculations.

3.3.3 Tumor Segmentation
Brain tumors were segmented semi-automatically from multimodal image acquisitions (T1w,
postcontrast T1w, T2w and FLAIR) using the software application ITK-SNAP 24. For patients
with non-enhancing tumors, the tumor was defined using the T2w/FLAIR hyperintense volume,
while for enhancing tumors, the tumor volume was defined as the T1w contrast-enhancing and
T2w/FLAIR hyperintense regions.

3.3.4 Homotopic Connectivity in Normal-Appearing Brain
To perform group-level HC analysis across the entire cortex using mirrored parcels, the left
hemisphere of the 200-parcel version of the Schaefer et al. atlas was arbitrarily selected with
each parcel assigned to one of seven resting-state networks27. The parcels (n = 100) were axially
reflected to produce mirroring parcels in the right hemisphere resulting in 100 homotopic pairs
for comparison. This is similar to the voxel-mirrored approach used by prior studies 17,22. The
BOLD timeseries of all voxels within each parcel were averaged together to create parcelspecific timeseries. Using Pearson correlation, the BOLD timeseries of each parcel was
correlated to its homologous BOLD timeseries in the opposite hemisphere and Fisher’s ztransformed. Lesioned voxels were not included in HC calculations and parcels retaining less
than 20 unaffected voxels were removed. This was motivated to preserve information of parcels
with mixed content similar to previous reports 28,29. To compare to healthy subjects, each control
was replicated (1-2 times) and randomly assigned to a glioma patient and treated identically i.e.,
voxels corresponding to tumor-affected areas in glioma patients were also removed in the
64

controls for timeseries calculations29. HC differences between controls and glioma patients were
assessed by averaging the connectivity strength of all the retained pairs (global HC) or
subdividing the parcels into cortical locations30 or resting-state networks and averaging the
parcels within each subcategory.

3.3.5 Homotopic Connectivity Between Tumor and Contralesional
Hemisphere
To assess homotopic connectivity between tumor-disrupted areas and mirrored parcels (TC),
parcels with at least 20 lesioned voxels were separately analyzed by correlating the averaged
lesioned voxel timeseries for each parcel with the corresponding homotopic parcel and was
Fisher’s z-transformed. TC was then averaged for each parcel affected.

3.3.6 Normalized Connectivity
TC and HC for both LGG and HGG patients were normalized to their lesion-matched controls to
compare interhemispheric connectivity distributions of tumor-disrupted areas and normal
appearing brain (Figure S3.1.).

3.3.7 Hemodynamic Lag Analysis
Homotopic lag was measured as previously described21 for each brain voxel by cross-correlating
its BOLD timeseries to the homotopic voxel timeseries in the opposite hemisphere and
identifying the time shift at which the cross-correlation between the voxel pair was maximal over
the range ±5 TR. Parabolic interpolation was performed to improve the estimation of the
timepoint 31. To assess lags between homotopic parcels, the absolute lag of all voxels within each
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parcel was calculated and averaged together.

3.3.8 Statistical Analysis
Statistical analyses were performed in MATLAB (2017b, Natick, Massachusetts), Prism
(GraphPad, San Diego, California); Excel (Microsoft Corporation, Redmond, Washington), and
R (R Foundation for Statistical Computing, Vienna, Austria). Two-sample (unpaired) t-tests were
used to compare connectivity differences between subject groups where applicable. Simple linear
regressions were implemented to evaluate associations between tumor severity and HC or
hemodynamic lag. For tests of HC and overall survival associations, the Dubey and ArmitageParmer procedure for multiple comparisons correction was implemented32. The log-rank test was
used to compare Kaplan-Meier survival curves of HC of the somatomotor network (SMN) and
dorsal attention network (DAN) (n = 42). Additionally, univariate and multivariate Cox
regressions were employed to compare the effects of covariates (age, tumor volume, SMN HC)
on survival. The patients evaluated by Cox regression were high-grade gliomas (WHO Grade IV)
and IDH wild-type (n = 42). A p-value of 0.05 denoted statistical significance.

3.4 Results
3.4.1 Subject characteristics
Fifty-nine glioma patients (mean age; 57.5 ± 14.5, 19 females) and thirty healthy controls (mean
age; 65.9 ± 10.8, 14 females) were retrospectively reviewed and included in this study (Table
3.1). Of the 59 patients, 9 were histologically diagnosed as low-grade (WHO grade II) glioma
and 50 were diagnosed as high-grade (WHO grade IV) glioma. Low-grade glioma (LGG)
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patients were diagnosed as oligodendrogliomas (n = 4), oligoastrocytoma (n = 4) or astrocytoma
(n = 1). All high-grade glioma (HGG) patients were diagnosed as glioblastoma multiforme
(GBM). All LGG patients were IDH-1 mutated (n = 9) while all HGG patients were IDH
wildtype (n = 50). Figure 3.1A shows lesion distribution heatmaps to illustrate the tumor
heterogeneity of LGGs and HGGs in the present patient sample. LGGs were more represented in
the left hemisphere (7/9, 78.8%). For HGGs, there was a slight preference for tumors in the left
hemisphere (30/50 patients, 60%). For patients with reported overall survival (all HGG, n = 42),
mean overall survival was approximately 17.1 ± 11.6 months. A template parcellation was used
to extract HC between homotopic pairs for each patient (Figure 3.1B).

Table 3.1 Characteristics of glioma and control subjects
Patient and Control characteristics
Controls

All Patients

65.9 ± 10.8 (53-89)

57.5 ± 14.5 (21-83)

Female

14

19

Male

16

40

-

70.9 ± 53.4

Astrocytoma

-

1

Oligoastrocytoma

-

4

Oligodendroglioma

-

4

Glioblastoma

-

50

Age, mean ± SD (Range)
Sex, n

Tumor Volume (cm3)
Tumor histology, n

WHO grade, n
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II

-

9

IV

-

50

Wildtype

-

50

Mutated

-

9

-

17.1 ± 11.6 (1.6 - 59.2)

IDH mutation status, n

Overall survival*, mo, range

*Overall survival was known for only HGG patients (n = 42)

3.4.2 HC is robustly related to glioma severity
Visually, HC in normal-appearing brain appeared to be generally strong in controls, weaker in
LGG patients, and even lower in HGG patients (Figure 3.1C). Quantitatively, this was
demonstrated as HC in HGG patients, was significantly lower than both LGG (two-sample t-test,
t = 3.49, P = 0.0021, Bonferroni corrected) and healthy controls (two-sample t-test, t = 10.67, P
< 0.0001, Bonferroni corrected) (Figure 3.1D). Although, the mean of HC in LGG (mean =
0.79) was lower than that of controls (mean = 0.88), there was no significant difference between
them (two-sample t-test, t = 2.2, P = 0.089, Bonferroni corrected).
The association between HC and tumor malignancy (Figure 3.1D) may be driven by
parcels belonging to certain cortical locations or resting-state networks. Therefore, to investigate
this possibility, we aggregated parcels by both cortical lobe (Figure 3.2A, B) and RSNs (Figure
3.2C, D). When grouped by cortical locations, the linear trend persisted for all regions with HGG
patients consistently demonstrating lower HC on average compared to LGG patients and controls
(Figure 3.2B). This effect was statistically significant for all cortical areas. The most variance
was explained for the parietal lobes (R2 = 0.53, P < 0.00001) and the least explained variance
was found for the temporal lobes (R2 = 0.30, P < 0.000001). When grouped by RSNs, a similar
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robust effect was observed in all networks except LIM (R2 = 0.0088, P = 0.31) (Figure 3.2D).
For RSNs, the most variance was explained for the ventral attention network (VAN) areas (R2 =
0.52, P < 0.00001).

Figure 3.1. Assessing HC in low- and high-grade glioma patients. (A) Heatmaps showing tumor
density of low-grade gliomas (LGG) (top) and high-grade gliomas (HGG) (bottom) in the 59patient sample. (B) Location of homotopic pairs used for connectivity analyses. (C) Colormaps
depicting FC of the 100 homotopic pairs in healthy controls (top), LGG (middle) and HGG
(bottom) patients. Warmer colors indicate stronger FC while cooler colors indicate weaker FC.
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(D) Global homotopic FC for each subject group obtained by averaging the tumor-free
homotopic pairs in individual subjects. Controls were replicated to mimic the glioma tumor
distributions with subsequent voxels removed prior to conducting connectivity analyses. HGG
patients had significantly greater global homotopic FC than both LGG patients (t = 3.5, P =
0.002) and controls (t = 10.7, P <0.0001). LGG patients were not significantly lower than
controls (t = 2.2, P = 0.089). P-values were Bonferroni corrected for 3 tests.

Figure 3.2 HC varies by cortical location and resting-state network but show robust associations
with tumor grade. (A) Structural atlas template depicting cortex subdivided into frontal, parietal,
insular, temporal, and occipital lobes. (B) HC in controls, LGG and HGG patients by cortical
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lobe. Across all cortical lobes there was a significant negative association between HC and
clinical severity. (C) Resting-state network (RSN) parcellation used to identify HC. VIS: visual
network; SMN: somatomotor network; DAN: dorsal attention network; VAN: ventral attention
network; LIM: limbic network; FPC: fronto-parietal control network; DMN: default mode
network. (D) HC in controls, LGG and HGG patients by RSN. Except for LIM, HC in all RSNs
was significantly negatively associated with clinical severity.

To further investigate the association between HC and glioma severity, we evaluated the
potential effects of tumor size and TC. Figure 3.3A compares the effect of tumor size on HC in
both LGG and HGG patients. In both cases, there was no significant correlation between tumor
volume and HC although HC was slightly weaker in larger tumors for HGG patients (LGG: R2 =
0.007, P = 0.82; HGG: R2 = 0.051, P = 0.11). In a subsequent analysis, we assessed the
relationship between HC and TC. Interestingly, TC was only associated with HC for HGG
patients (R2 = 0.18, P = 0.0025), but not for LGG patients (R2 = 0.025, P = 0.68) (Figure 3.3B).
We also evaluated TC and HC for LGG and HGG patients normalized to lesion-matched controls
(Figure S3.1). HGG showed significantly lower HC and TC than LGG (two-sample t-test; LGG
TC vs HGG TC; t = 2.82, P = 0.0067, LGG HC vs HGG HC; t = 3.23, P = 0.0021).
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Figure 3.3 Investigating potential HC covariates. (A) Evaluating impact of tumor volume on
homotopic FC in normal-appearing brain. In both LGG and HGG patients, there was not a
statistically significant relationship between tumor volume and HC (LGG: R = 0.084, P = 0.82;
HGG: R = -0.23, P = 0.11). (B) Determining impact of FC of tumor-disrupted areas on FC in
normal-appearing brain. In LGG patients, tumor-disrupted FC was not associated with FC of
normal-appearing brain regions (R = -0.16, P = 0.68). However, there was a strong relationship
between tumor-disrupted FC and FC of normal-appearing brain in HGG patients (R = 0.43, P =
0.0025).
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3.4.3 Hemodynamic lag is associated with HC in glioma patients
The brain-wide relationship between HC and tumor severity suggests that a systemic driver may
be involved. A homotopic lag analysis was performed for all patients and controls by crosscorrelating the timeseries of each voxel in the ipsilesional hemisphere to its contralesional
homologue and measuring the peak correlation time shift (Figure 3.4A). Figure 3.4A illustrates
the contralesional lag maps of two LGG patients and two HGG patients. Regions of
hemodynamic lagging and leading relative to the ipsilesional hemisphere can be observed. To
quantify the global relationship between tumor grade and lag, we averaged the mean absolute lag
of every parcel. Regression analysis found a strong association between hemodynamic lags and
tumor grade with greater lags observed in HGG patients (R2 = 0.13, P < 0.0001) (Figure 3.3B).
HC was then correlated with lag across subject groups. No correlation was observed between HC
and lags in controls (R = -0.012, P = 0.93) (Figure 3.3C). However, HC and lag showed a strong
association in both LGG (Figure 3.3D) and HGG (Figure 3.3E) patients although this was only
statistically significant for HGG patients (LGG: R2 = 0.31, P = 0.12; HGG: R2 = 0.22, P =
0.0006).
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Figure 3.4 HC is correlated with homotopic lags in glioma patients. (A) Homotopic lag maps for
2 LGG and 2 HGG patients. Since each voxel in the ipsilesional hemisphere is cross-correlated
with its contralesional homologue to calculate lag, only the lags found in the contralesional
hemisphere are displayed. The ipsilesional structural T1-weighted images are displayed to show
gliomas at corresponding axial slices. The time-shift scale ranges from -4 repetition time (TR) to
+4 TR. (B) Mean absolute homotopic lag across the cortex is significantly associated with
clinical severity (P < 0.0001). (C) HC is not correlated to homotopic lag in controls (P = 0.93).
(D) HC is correlated with homotopic lag in LGG patients, but this was not statistically significant
(P = 0.12). (E) HC was significantly correlated with homotopic lag in HGG patients (P =
0.0006).
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3.4.4 Strength of HC relates to survival
Since tumor grade is strongly associated with patient outcomes and strong HC is a feature of
normal brain function, we investigated whether HC could predict overall survival (OS) in our
cohort of HGG patients (n = 42) at the time of their initial diagnosis. HC across all networks
(Mean RSN) was positively associated with OS, but this was not statistically significant (R2 =
0.092, P-adjusted = 0.071) (Figure 3.4A). The contribution of HC in each RSN to OS was
separately evaluated. SMN (R2 = 0.17, P-adjusted = 0.04) and DAN (R2 = 0.14, P-adjusted =
0.027) were significantly correlated with OS.
To further evaluate the relevance of SMN and DAN HC to OS, the patients were median
split into low and high FC groups for each network, and survival was compared using KaplanMeier survival analysis (Figure 3.4B). This revealed a significant difference in survival for
SMN (log-rank test, χ2 = 4.7, P = 0.031) but not for DAN (log-rank test, χ2 = 2.2, P = 0.13).
Patients with low SMN HC had a median survival of 11.6 months compared to 17.1 months in
the high SMN group. Univariate Cox regression showed that SMN HC was a significant
predictor of overall survival (Table S3.1). After accounting for the potential influences of age
and tumor size, SMN HC still maintained this effect (HR: 0.50, 95% CI: 0.25-0.97, P = 0.04).
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Figure 3.5 Overall survival for HGG patients (n = 42) is associated with the HC of specific
RSNs. (A) Plots depicting the association between RSN-specific HC and overall survival. Only
SMN (P = 0.014) and DAN (P = 0.027) had statistically significant correlations with overall
survival after multiple-comparisons correction. (B) Kaplan-Meier survival analysis for HGG
patients comparing overall survival of patients with low SMN HC and patients with high SMN
HC. Patients with high SMN HC had significantly longer median overall survival than patients
with low SMN HC after accounting for tumor volume and age (HR: 0.50, 95% CI: 0.25-0.97, P
= 0.04). (C) Kaplan-Meier survival analysis for HGG patients comparing overall survival of
patients with low DAN HC and patients with high DAN HC. There was no overall survival
difference between these two groups organized by DAN HC (log-rank test, χ2 = 2.2, P = 0.13).
76

3.5 Discussion

Whole-brain connectivity disruptions in glioma patients have been previously reported and
demonstrate a remarkable association with tumor aggressiveness and cognitive impairments 3.
Despite the potential clinical implications of these findings, the underlying functional
connections responsible for these phenomena are not well understood. As interhemispheric
communication heavily relies upon transcallosal pathways, we used the well-characterized
concept of HC to investigate these pathways as a candidate for tumor-induced dysfunction in a
sample of LGG and HGG patients16,22,33. HC derived from 30 healthy adults was used as a
control to evaluate glioma-specific effects. Consistent associations between HC and tumor
severity were observed (Figure 3.1C-D, Figure 3.2). TC was only significantly associated with
HC in HGG patients (Figure 3.3). Additionally, hemodynamic lags between homotopic areas
were strongly associated with tumor grade (Figure 3.3). Importantly, HC disruptions in HGG
patients were also significantly associated with overall survival (Figure 3.4).
The highly symmetric nature of interhemispheric anatomical connections in the brain
facilitates strong and stable functional connectivity between homologous areas12,23,34. As a result,
the growth of unilateral tumor lesions can lead to distorted connections that impact HC19,35. The
extent of disruption, however, is dependent upon several factors. Our findings suggest that tumor
grade plays a critical role in the distortion of HC in glioma patients. It is not surprising that
connectivity between tumor-altered cortical regions and their contralateral homologues would be
severely weakened (Figure S3.1). Gliomas can displace normal brain anatomy, including the
astrocytic endfeet responsible for maintaining neurovascular coupling; a crucial component of
functional connectivity 1,36,37. Additionally, lack of adequate oxygen in the microenvironment or
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glioma-secreted growth factors can induce neuronal cell death 1,38. However, it is intriguing that
LGGs disrupt HC in these regions significantly less than HGGs. Previous work has shown that
functional areas can be found within tumor boundaries 9,39 with greater frequency in LGGs
compared to HGGs 40. Therefore, it is plausible that preserved function could result in less
disrupted HC. The relationship between TC and HC being only associative for HGGs also
suggests a greater functional tumor burden on the brain in HGGs. This greater burden supports
the findings of significantly lower HC in HGGs across distinct locations and RSNs (Figure 3.2)
as well as the greater amount of brain-wide functional alterations found in previous studies 3,4.
Across several measures, HGGs had greater variance than LGGs and controls. Although
this may be partly due to the low sample size of LGGs in this study (n = 9), a more intriguing
possibility is that the biologic heterogeneity of HGG induces variability in HC across patients.
HGGs consist of heterogenous cell subgroups which promote tumor proliferation and invasion
by subverting the microenvironment and normal signaling pathways of the brain parenchyma
1,41–44

. Moreover, recent studies have shown that HGGs can communicate via tumor microtubes

that are grossly lacking in less-invasive gliomas 2,45. Such pronounced cellular heterogeneity may
result in substantial variability in FC disruptions. Indeed, our previous work found large
intratumor FC variability in GBM (HGG) patients that supports this hypothesis9.
Finding robust HC disruptions in glioma patients prompted us to consider altered
neurovascular mechanisms given the hemodynamic nature of BOLD resting-state signals.
Hemodynamic delays or lags due to cerebral lesions have been investigated primarily in stroke
patients with limited studies focused on glioma 20,21,46,47. In stroke, areas of hypoperfusion caused
by cerebrovascular infarcts are correlated with regions of temporal delay in the BOLD signal,
suggesting that the altered vasculature precludes a normal neurovascularly-coupled BOLD
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response8,20,46. As a result, these lags considerably alter functional connectivity measures 8.
Recent glioma studies in mice have shown similar findings As tumors grow, they increase the
disruption of bilateral neurovascular coupling and desynchronization of neural activity 21,47. This
neurovascular uncoupling can result in homotopic lags that have been reproduced in human
glioma patients21. Thus, our finding of greater homotopic lags in more aggressive tumors
provides complementary insights to those results, suggesting that tumor biology may account for
some differences. In LGGs and HGGs, lags explained 31% and 22% of the variance respectively,
leaving open the possibility of unexamined neuronal contributions as shown in the work by
Montgomery and colleagues 47.
Strong synchrony of activity between homologous regions is a mainstay of healthy brain
functioning12,16,22,23. Therefore, the degree of its impairment may act as a surrogate for global
brain health. In fact, global HC was correlated with overall survival in HGG patients although
this was not statistically significant. However, when restricting HC to specific brain networks,
both SMN and DAN were significantly correlated with overall survival (Figure 3.4). In stroke
studies, HC correlated with behavioral impairments and subsequent recovery 18,48. However, to
our knowledge, no one has reported previously reported a link between HC and overall survival
in glioma patients. Although DAN did not produce a statistically significant survival difference
between low and high FC patients, SMN retained its significance after accounting for covariates.
SMN HC is significantly correlated with motor deficits in stroke and brain tumor patients 18,19. In
glioma patients, motor deficits have been shown to alter quality of life and are independently
associated with poor survival 49,50. Consequently, the present results support the SMN as an
integral network for survival in HGG patients. However, it remains to be seen whether treatment
strategies aimed at enhancing the HC of this network can confer a survival benefit.
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Certain limitations may impact the results of this study. The low sample size of LGG
patients prevented further analyses beyond finding associations across the tested domains. Future
studies incorporating more LGG patients could for example, investigate the impact of tumor
biology on network disruption susceptibility. Additionally, as all LGG patients were IDH-mutant
and all HGG patients were IDH-wildtype, we were unable to test whether IDH-status conferred
differences in HC beyond WHO grade status. Understanding how tumor genetics alters local and
global brain function could result in novel strategies for treatment3. As rs-fMRI cannot measure
cellular activity, animal studies could play a critical role in deciphering the tumor-brain network
interactions that are responsible for our findings.
In this study, we show that HC is altered in glioma patients and that this disruption
depends on tumor grade. Furthermore, the strength of HC in the somatomotor network is
significantly associated with overall survival. Thus, HC may provide additional information for
treatment planning in glioma patients.

3.6 Supplemental Table
Table S3.1. Univariate and multivariate survival analysis for HGG patients (n = 42)

Characteristic

Univariate Cox

Multivariate Cox

HR (95% CI)

P-value

HR (95% CI)

Pvalue

Age at initial Diagnosis

1.01(0.97,1.04)

0.80

1.01 (0.97, 1.05)

0.65

Tumor volume (cm3)

1.01 (1.00,1.02)

0.0076

1.011 (1.00, 1.019)

0.0085

SMN HC = High

0.50 (0.26, 0.95)

0.034

0.50 (0.26, 0.97)

0.04
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3.7 Supplemental Figure

Figure S3.1. Normalized connectivity of tumor-disrupted areas (TC) and normal-appearing brain
(HC) in LGG and HGG patients. TC was markedly reduced (one-sample t-test; LGG: t = 3.3, P =
0.011; HGG: t = 17.46, P < 0.00001). HC was also significantly reduced for both LGG and HGG
patients (one-sample t-test; LGG: t = 2.82, P = 0.023; HGG: t = 11.13, P < 0.00001). TC was
less attenuated in LGG patients compared to HGG patients (two-sample t-test; LGG vs HGG: t =
2.82, P = 0.0067). There was a greater reduction of HC in HGG patients compared to LGG
patients (LGG vs HGG: t = 3.23, P = 0.0021).
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Chapter 4: Conclusions and Future
Directions
4.1 Summary
Here we show that hypotheses driven by the interactions between gliomas and the brain
parenchyma can be successfully answered using preoperative rs-fMRI. Although the
spatiotemporal resolution of rs-fMRI precludes the ability to investigate microscale or cellular
level effects, it serves as a suitable platform for examining macroscale alterations in the brain
that may be the overt consequences of these effects. Furthermore, we demonstrated that certain
functional connectivity changes observed before treatment had prognostic associations with the
overall survival of malignant glioma patients that were independent of known clinical covariates.
This suggests that rs-fMRI-based biomarkers may one day be successfully employed clinically to
provide patients and their caregivers with more informed options for therapy.
In Chapter 2, we asked whether the phenomena of intratumor function previously
observed using direct electrical stimulation mapping1,2 and magnetic source imaging3 could be
identified using rs-fMRI. Our technique did not answer this question directly as rs-fMRI uses
statistical associations between BOLD signals (functional connectivity) while the former
techniques measured electrical and magnetic changes directly associated with the underlying
neuronal activity. Therefore, with our method we were only able to probe how correlated areas
within the tumor were to extratumoral regions. This served as a proxy for the preservation of
intratumor function but allowed us to go beyond eloquent cortex and investigate function more
broadly. As such, we were the first group to report intratumor functional connectivity and found
that it was a widespread observation in glioblastoma. Notably, there did not appear to be any
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resting-state network specificity for preserved intratumor functional connectivity. This suggested
that glioblastoma indiscriminately altered functional connections. Moreover, intratumor
functional connectivity appeared to exist in expected locations (i.e., higher in the contrastenhanced tumor regions and significantly lower in necrotic areas) thus supporting the viability of
our findings. Most importantly, we found that intratumor functional connectivity strength was an
independent predictor of overall survival, with higher connectivity associated with longer
survival. We hypothesized that this was due to tumors with more retained connections being less
malignant. However, future studies (see Section 4.2) will be needed to validate these
mechanisms. As our survival analyses used patients with only IDH-wildtype glioblastoma, this
meant that our technique was successfully able to stratify this high mortality group. Therefore,
although this study was primarily proof of concept, it has opened new and exciting avenues for
probing glioma effects on brain function with clinical significance.
With Chapter 2 focused on intratumor functional connectivity, we decided to investigate
the impact of glioma biology on large-scale interhemispheric functional connectivity in Chapter
3. We chose to apply the principle of homotopic connectivity for these analyses as this is a wellestablished concept in neuroscience4–7. Additionally, by accounting for tumor-affected areas we
were able to separate homotopic connectivity changes that were directly and indirectly related to
the tumor mass. Although the sample size of low-grade glioma patients was lower than highgrade glioma patients, we were still able to find consistent differences between these two groups.
This suggests that tumor biology has a strong effect on homotopic connectivity disruptions.
High-grade glioma (glioblastoma) patients, on average, had lower homotopic connectivity than
low-grade gliomas, which in turn tended to be lower than healthy controls. This linear
relationship was largely reliable across the cortical lobes and resting-state networks. An
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awareness of the underlying mechanisms responsible for generating the BOLD signal and the
impact that lesions could have on the vasculature prompted us to investigate hemodynamic lags.
Since homotopic lags in gliomas were recently reported 8, we wanted to know whether tumor
biology altered its severity and contributed to the homotopic connectivity differences we found.
We identified a strong linear relationship between tumor severity and lags as well as between
homotopic connectivity and lags in glioma patients (but not in controls). These findings
suggested that lags are dependent on tumor burden and influence homotopic connectivity. With
the relationship between tumor severity and homotopic connectivity established, we examined its
potential role as a prognostic indicator for overall survival in IDH-wildtype glioblastoma
patients. We found a positive relationship between homotopic connectivity and overall survival,
which was statistically significant for the somatomotor network. As homotopic connectivity
disruptions are associated with motor deficits,9 and motor deficits are associated with poor
outcomes10,11, our findings may have provided a linkage between functional connectivity and
survival outcomes. More studies will need to be performed to confirm this finding (see Section
4.2).
In summary, this thesis has provided strong evidence for the usage of rs-fMRI to study
not only glioma-specific effects on brain function but also to derive clinically relevant
information about patient prognosis. The ability to identify these measures preoperatively would
enable more informed treatment planning and potentially improved outcomes. However, this
work is still in its infancy with several possible avenues to explore. In the following section, I
will discuss a few recommendations to carry on this research.

4.2 Future Directions
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4.2.1 Demographics
Firstly, given the complexity and heterogeneity of gliomas, particularly malignant gliomas,
studies would benefit from larger sample sizes of low- and high-grade glioma patients to
improve the generalizability of results. With more patients, we could investigate the effects of
additional covariates such as race, education level, genetics, chemotherapy, radiotherapy, surgery
type, antiepileptic medication, and iatrogenesis on resting-state measures while limiting the risk
of overfitting our models. Larger sample sizes would also enable the use of more robust machine
learning algorithms for outcome predictions.

4.2.2 Data Acquisition
For the present work, patient scans were obtained prior to surgery; therefore, we were unable to
longitudinally investigate resting-state changes over time i.e., post-surgery, post-chemotherapy,
and post-radiotherapy. Having structural and functional scans at these milestones may facilitate
investigations into the evolution of BOLD signals during treatment and may provide insight into
the effect of treatment on brain function and glioma-induced alterations.
As gliomas may result in neurovascular uncoupling12, complementary techniques can be
employed to examine this phenomenon. One approach is the use of cerebrovascular reactivity
mapping which tests cerebral blood flow changes to vasoactive stimuli13,14. Along with rs-fMRI,
one could investigate how neurovascular uncoupling alters intratumor functional connectivity.
Additionally, to my knowledge, no one has investigated whether neurovascular uncoupling in
glioma patients is associated with overall survival or recurrence, so this technique may elucidate
these relationships. To overcome the limitations posed by neurovascular uncoupling, techniques
that are more directly related to neuronal activity such as electroencephalography (EEG) or
magnetoencephalography (MEG) may be valuable. One could examine how related intratumor
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functional connectivity is to intratumor function and whether they provide complementary
information. These examinations would be useful in discerning the biological significance of
intratumor functional connectivity.
In addition to these methods, standard clinical techniques such as diffusion tensor
imaging (DTI) and arterial spin labeling (ASL) would also provide complementary information
to rs-fMRI. With DTI, we could investigate structural connectivity changes in glioma patients,
while ASL enables cerebral blood flow measurements and would complement the lag analyses
performed using rs-fMRI15,16.
Finally, as studies have shown that BOLD signal quality improves with longer scan
times17–19 and enables precision functional mapping20,21, it may be beneficial to increase the
length of clinical scan times. Although this may be difficult to implement practically, it is worth
considering if the information gleaned could have tangible benefits for patients.

4.2.3 Neurocognitive testing
Pre- and post-treatment cognitive testing would be an excellent source of data to relate the rsfMRI findings to behavior22. This would greatly expand upon the possible experiments as we
would be able to examine how glioma-induced changes in functional connectivity is manifested
behaviorally, similar to past stroke studies15,23,24. Moreover, we would be able to study the
consequences of treatment on function, behavior, and outcomes, improving our understanding of
their complex interactions.

4.2.4 Additional Experiments
Comparing intratumor FC and homotopic FC: It would be informative to find out whether
intratumor FC and homotopic FC provided independent prognostic value. If independent, these
measures may improve overall survival predictions when combined and support the use of rs90

fMRI for finding radiologic biomarkers.
Tumor recurrence: The measures employed in this thesis can be used to investigate progressionfree survival like our overall survival analyses. Additionally, since intratumor FC mapping
differentiates between high and low connected areas, it may be intriguing to test whether these
locations are associated with tumor recurrence by combining preoperative rs-fMRI with
postoperative follow-up scans. We can hypothesize that tumor recurrence would be associated
with areas of low intratumor connectivity as those regions potentially correspond to greater
tumor burden.
Histopathology assessments: Combining biopsy and histopathology data with structural and
functional imaging would enable investigations into the cellular underpinnings of both
intratumor FC and homotopic FC findings. With the former, we would be able to study whether
histology supports the notion of retained neuropil in areas of high intratumor FC relative to areas
of low intratumor FC. With the latter, we would investigate how gliomas cells and necrosis alter
the connections needed for homotopic connectivity.
Graph theory: With graph theory, we can theoretically investigate the importance of specific
brain regions for particular functions25. Therefore, these analyses may enable us to model the
impact of glioma location or its surgical removal on whole-brain network parameters and
determine how this relates to behavioral outcomes and survival.
Pre-processing: Several pre-processing pipelines have been developed for rs-FMRI with
differing parameters. Moreover, these pipelines were created for use in normal human subjects
for research purposes and not for clinical application. Therefore, certain steps may reduce the
information that would benefit studies of glioma-induced changes. This could include the white
matter and global signal regression steps used to improve signal quality. As a result, specific
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aspects of pre-processing can be investigated to determine its usefulness for glioma imaging.
Interventional studies: As both intratumor FC and homotopic FC are positively associated with
longer overall survival, it may be worthwhile to investigate whether certain rehabilitation
strategies would increase baseline connectivity of those regimes and subsequently improve
patient outcomes.
Animal studies: Animal models can be used to study the underlying mechanisms of gliomainduced changes on brain function as well as hemodynamic activity and support the patient
findings.

4.3 Concluding Remarks
Gliomas utilize a multiplicity of molecular, cellular, and environmental factors to remain an
incurable and devastating disease. For this reason, expertise in several domains is required to
identify novel treatment strategies to improve quality of life and prolong survival, with the
audacious goal of ultimately subduing this hydra 26. For this reason, expanding the role of rsfMRI beyond eloquent cortex mapping for glioma patients is a worthwhile endeavor. rs-fMRI
provides readily accessible patient-level data that facilitates novel insights into glioma-brain
interactions. These findings, along with subsequent studies may usher in a new era for biomarker
discovery and therapies.
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